H&T Finance Director Fenerty Receiving Help After Leukaemia Diagnosis

LONDON (Alliance News) - H&T Group PLC said Wednesday its Finance Director Steve Fenerty has ...

Alliance News 14 February, 2018 | 6:03PM
Email Form

LONDON (Alliance News) - H&T Group PLC said Wednesday its Finance Director Steve Fenerty has been diagnosed with leukaemia and is receiving treatment, emphasising he remains actively involved in running the pawnbroker.

Fenerty - finance head since 2013 - is said to be receiving first class treatment. Although still actively involved in running the AIM-listed firm, the company said he was receiving assistance in his role from both internal staff member and external appointments.

"We have a clear strategy headed by CEO John Nichols," H&T Chairman Peter McNamara said. "Steve Fenerty is well supported by Tatiana Hagan, part of a first class finance team he has developed over recent years. Steve Fenerty will have further assistance given by an interim appointment from an experienced financial officer from within the sector."

Shares in H&T closed 1.0% lower at 339.00 pence on Wednesday.

By Ahren Lester; ahrenlester@alliancenews.com.

Copyright 2018 Alliance News Limited. All Rights Reserved.

Email Form
Securities Mentioned in Article
Security Name Price Change (%) Morningstar
Rating
H&T Group PLC 321.15 GBX 1.95 -
About Author Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.